Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong

NCT03457961 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT03457961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03457961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Unknown status
Start date
July 23, 2016
Completion date
July 1, 2021
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

focal epilepsy, generalized epilepsy, partial seizures, simple